Showing results (651-660 of 4,366) with videos related to

Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|May 4, 2002
Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr miceTsunemichi Tsukahara, Yasuhiko Makino, Takayuki Fujii, et al.
Clinical Immunology (Orlando, Fla.)|February 2, 2010
Antimicrobial peptides: general overview and clinical implications in human health and diseaseEduardo Guaní-Guerra, Teresa Santos-Mendoza, Saúl O Lugo-Reyes, et al.
Clinical Immunology (Orlando, Fla.)|February 4, 2010
Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertantsBrian R Davis, Qing Yan, Jacquelin H Bui, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2018
CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiontNatalia Shulzhenko, Xiaoxi Dong, Dariia Vyshenska, et al.
Clinical Immunology (Orlando, Fla.)|September 17, 2018
Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complicationsDelphine Turpin, Adeline Furudoi, Marie Parrens, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2018
The role of surface molecule CD229 in Multiple MyelomaMichael Olson, Sabarinath Venniyil Radhakrishnan, Tim Luetkens, et al.
Clinical Immunology (Orlando, Fla.)|August 18, 2018
Th1/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosusAnastasia Tsanaktsi, Elena E Solomou, Stamatis-Nick C Liossis
Clinical Immunology (Orlando, Fla.)|August 27, 2018
Defective TLR9-driven STAT3 activation in B cells of patients with CVIDArturo Borzutzky, Ingrid Rauter, Ari Fried, et al.
Pageof 437